These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2572313)
1. Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence. Francis PT; Bowen DM Can J Neurol Sci; 1989 Nov; 16(4 Suppl):504-10. PubMed ID: 2572313 [TBL] [Abstract][Full Text] [Related]
2. Tacrine in relation to amino acid transmitters in Alzheimer's disease. Bowen DM; Steele JE; Lowe SL; Palmer AM Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197 [No Abstract] [Full Text] [Related]
3. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Summers WK; Tachiki KH; Kling A Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104 [TBL] [Abstract][Full Text] [Related]
4. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type. N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295 [No Abstract] [Full Text] [Related]
5. Tetrahydroaminoacridine and Alzheimer's disease. Levy R Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126 [No Abstract] [Full Text] [Related]
6. Tetrahydroaminoacridine in Alzheimer's disease. Walsh AC BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129 [No Abstract] [Full Text] [Related]
7. Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results. Boller F; Forette F Biomed Pharmacother; 1989; 43(7):487-91. PubMed ID: 2684292 [TBL] [Abstract][Full Text] [Related]
10. Tetrahydroaminoacridine and lecithin for Alzheimer's disease. N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447 [No Abstract] [Full Text] [Related]
11. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?]. Drukarch B; Stoof JC Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771 [No Abstract] [Full Text] [Related]
12. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. Chatellier G; Lacomblez L BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease. Kumar V; Becker RE Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):478-85. PubMed ID: 2684868 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study. Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720 [TBL] [Abstract][Full Text] [Related]